Evaluation of asthma control and quality of life after 6 months of treatment with FDC Budesonide/Formoterol-BOREAS study.

P. Bakakos (Athens, Greece), D. Papakosta (Thessaloniki, Greece), E. Zervas (Athens, Greece), K. Katsoulis (Thessaloniki, Greece), A. Ginis (Attica, Greece), M. Bertoli (Attica, Greece), K. Apostolidou (Attica, Greece), S. Loukides (Athens, Greece)

Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Session: Asthma treatment: cohorts and real-world studies
Session type: Thematic Poster
Number: 2567
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Bakakos (Athens, Greece), D. Papakosta (Thessaloniki, Greece), E. Zervas (Athens, Greece), K. Katsoulis (Thessaloniki, Greece), A. Ginis (Attica, Greece), M. Bertoli (Attica, Greece), K. Apostolidou (Attica, Greece), S. Loukides (Athens, Greece). Evaluation of asthma control and quality of life after 6 months of treatment with FDC Budesonide/Formoterol-BOREAS study.. 2567

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluation of quality of life (QOL) in asthma patients during 6 months formoterol therapy
Source: Eur Respir J 2001; 18: Suppl. 33, 44s
Year: 2001

Asthma control and quality of life in asthmatic patients treated for 6 months with FDC Budesonide/Formoterol - BOREAS study: a subgroup analysis in patients with comorbidities
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019


Quality of life and symptoms improvement after 6 months treatment with roflumilast 500 μg daily in a large Greek COPD cohort
Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Year: 2013

Patients’ evaluation on asthma severity was related to level of asthma control and quality of life over seven years follow-up
Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Year: 2013

Impact of asthmatic patient satisfaction with the inhaler upon adherence, disease control and quality of life. Results of the ASCONA study
Source: International Congress 2017 – Pulmonary drug and devices delivery
Year: 2017

One year dynamics of life quality depending on the adherence to therapy in patients with bronchial asthma
Source: Annual Congress 2013 –Asthma at the bedside
Year: 2013

Does daily SMS increase adherence to asthma treatment? A three months follow-up study
Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches
Year: 2009


Assessment of quality of life in asthmatic children. A case- control study
Source: Annual Congress 2012 - Assessing and treating childhood asthma and allergy
Year: 2012


Quality of life in the PLATINO study 6 to 9 years later
Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases
Year: 2015


Health related quality of life in asthmatic subjects after 3 months treatment with inhaled corticosteroids
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015

TriOptimize VII: Improvement of health-related quality of life after 3 months treatmentwith extrafine single inhaler triple therapy in COPD patients in a real-world setting.
Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more
Year: 2020


Asthma control (AC) and quality of life (QoL) 3 months after pulmonary rehabilitation (PR)
Source: Annual Congress 2010 - Pulmonary rehabilitation: understanding and developing the intervention
Year: 2010

Quality of life, tuberculosis and treatment outcome; a case–control and nested cohort study
Source: Eur Respir J, 56 (2) 1900495; 10.1183/13993003.00495-2019
Year: 2020



A 1-day visit in a severe asthma centre: effect on asthma control, quality of life and healthcare use
Source: Eur Respir J 2016; 48: 726-733
Year: 2016



Improvement in HRQoL of COPD patients after 9 months‘ treatment with tiotropium bromide: use of a new scale for daily medical practice
Source: Eur Respir J 2005; 26: Suppl. 49, 290s
Year: 2005

Relationship between guideline treatment and health-related quality of life in asthma
Source: Eur Respir J 2004; 23: 718-722
Year: 2004



An increase in steps per day 6 weeks after pulmonary rehabilitation of COPD patients correlates with an improvement in quality of life
Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation
Year: 2020


Comparative assessment of optimized delivery systems on quality of life (QoL) and cooperation (CP) in asthma patients
Source: Eur Respir J 2004; 24: Suppl. 48, 591s
Year: 2004

What patients with IPF can expect concerning symptoms and quality of life during first six months of antifibrotic treatment?
Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia
Year: 2019

Changes of quality of life after short rehabilitation treatment in COPD patients: comparison between three groups of different age
Source: Eur Respir J 2006; 28: Suppl. 50, 556s
Year: 2006